Teva Pharmaceutical Industries Ltd. — AGM Information 2009

May 18, 2009

_________ false

C007��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310428P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267554 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 18/05/2009              Time of broadcast: 10:05 09:56:20

Reference: 2009-02-112296

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Complementary report for a report sent on date 07/05/2009 whose reference number was 2009-02-103743
Main details added/ completed:
Attached below are the voting card and the Company's proxy statement.

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 22/06/2009 at 16:30 the corporation will hold it's annual general meetingat Teva's executive offices at 5 Basel st., Petah Tikva, IsraelNumber of the security that entitles its holder to vote at the meeting: 629014The Number - as given by the Tel Aviv Stock Exchange

According to section 182 B of the Companies law, 5759-1999, only shareholders of record at the close of business 13/05/2009 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report proxyheb2009_isa.pdf

Attached hereto is the proxy statement proxyeng2009_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 15/03/2009
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: eyal@teva.co.il 2